TVM Life Science Ventures VI GmbH & Co KG's Net Worth
$13.7 Thousand
Who is TVM Life Science Ventures VI GmbH & Co KG?
TVM Life Science Ventures VI GmbH & Co KG does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CONCERT PHARMACEUTICALS, INC., PROTEON THERAPEUTICS INC, and Acer Therapeutics Inc..
SEC CIK
TVM Life Science Ventures VI GmbH & Co KG's CIK is 0001599744
Past Insider Trading and Trends
2014 was TVM Life Science Ventures VI GmbH & Co KG's most active year for acquiring shares with 7 total transactions. TVM Life Science Ventures VI GmbH & Co KG's most active month to acquire stocks was the month of January. 2014 was TVM Life Science Ventures VI GmbH & Co KG's most active year for disposing of shares, totalling 10 transactions. TVM Life Science Ventures VI GmbH & Co KG's most active month to dispose stocks was the month of September. 2014 saw TVM Life Science Ventures VI GmbH & Co KG paying a total of $3,698,336.58 for 2,512,500 shares, this is the most they've acquired in one year. In 2014 TVM Life Science Ventures VI GmbH & Co KG cashed out on 22,135,373 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CONCERT PHARMACEUTICALS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2,694.27% | 1.43M |
$14.00 |
—
| 1.48M |
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PROTEON THERAPEUTICS INC (TARA) Snapshot price: $1.9505
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
| +34.57% | 1.94M |
$7.30 | $3,719,997.62 | 7.56M |
Oct 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Acer Therapeutics Inc. (ACER) Snapshot price: $0.8675
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +16.15% | 333.33K |
$12.00 | $3,999,996.00 | 2.4M |
Dec 12
| |||
Form 4
|
∞
| 2.06M |
—
|
—
| 2.06M |
Sep 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||